deltatrials

Attention deficit hyperactivity disorder Trials in Taipei, Taiwan

Conditions / Attention deficit hyperactivity disorder / Taipei, Taiwan

Attention deficit hyperactivity disorder has been the subject of sustained clinical investigation across multiple research sites.

35 total trials for this combination

Showing top 10 of 35 trials

Trials

NCT ID Title Status Phase
NCT00916786 Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder COMPLETED
NCT00471354 A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine COMPLETED PHASE4
NCT00636818 Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) COMPLETED PHASE2
NCT00756158 Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD COMPLETED
NCT00962104 Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder COMPLETED PHASE3
NCT05502536 Effects of Fairytales on Preschool Children With Attention Deficit Hyperactivity Disorder UNKNOWN NA
NCT00485459 Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD COMPLETED PHASE3
NCT00916851 Clinical, Environmental, Neurocognitive, Brain Imaging, and Genetic Validity of Autism and ADHD COMPLETED
NCT03936491 The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study COMPLETED NA
NCT00529906 Endophenotype, Molecular Genetic Study on Attention-Deficit/Hyperactivity Disorder COMPLETED

Related Pages